Detalhe da pesquisa
1.
A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma.
Br J Haematol
; 178(3): 434-441, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28440559
2.
Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trial.
Lancet Oncol
; 17(5): 622-31, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27049457
3.
ENGAGE- 501: phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma.
Haematologica
; 101(8): 968-75, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27151994
4.
Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma.
Br J Haematol
; 171(4): 463-70, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26213141
5.
Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma.
Blood
; 119(18): 4123-8, 2012 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22371887
6.
Evaluation of US oncology electronic health record real-world data to reduce uncertainty in health technology appraisals: a retrospective cohort study.
BMJ Open
; 13(10): e074559, 2023 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37848301
7.
Current treatment strategies in Hodgkin lymphomas.
Curr Opin Oncol
; 24(5): 466-74, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22871744
8.
Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial.
Lancet Oncol
; 12(13): 1222-8, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22033282
9.
Histone deacetylase inhibitors in lymphoma.
Curr Opin Oncol
; 22(5): 431-6, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20683267
10.
Time from diagnosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma.
Leuk Lymphoma
; 61(12): 2939-2946, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32666852
11.
Experience with obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist in patients with relapsed or refractory classical Hodgkin lymphoma.
Blood
; 119(9): 2171-2, 2012 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22383790
12.
Phase I study of vorinostat in combination with standard CHOP in patients with newly diagnosed peripheral T-cell lymphoma.
Br J Haematol
; 162(1): 138-41, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23590726
13.
Brentuximab Vedotin: A Nursing Perspective on Best Practices and Management of Associated Adverse Events.
Clin J Oncol Nurs
; 22(4): E103-E114, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30035778
14.
Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma.
Leuk Lymphoma
; 59(4): 863-870, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28792260
15.
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay.
Blood Cancer J
; 8(6): 60, 2018 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29895903
16.
Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma.
Clin Cancer Res
; 19(24): 6882-90, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24097867
17.
Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy with interferon for advanced stage classic Hodgkin lymphoma: a 10-year follow-up study.
Leuk Lymphoma
; 53(5): 801-6, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22023528
18.
Phase I study of a novel oral Janus kinase 2 inhibitor, SB1518, in patients with relapsed lymphoma: evidence of clinical and biologic activity in multiple lymphoma subtypes.
J Clin Oncol
; 30(33): 4161-7, 2012 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22965964
19.
Phase I multidose-escalation study of the anti-CD19 maytansinoid immunoconjugate SAR3419 administered by intravenous infusion every 3 weeks to patients with relapsed/refractory B-cell lymphoma.
J Clin Oncol
; 30(22): 2776-82, 2012 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22753910
20.
Clinical development of panobinostat in classical Hodgkin's lymphoma.
Expert Rev Hematol
; 4(3): 245-52, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21668391